Yifeng Pharmacy (603939) - Total Liabilities

Latest as of September 2025: CN¥14.41 Billion CNY ≈ $2.11 Billion USD

Based on the latest financial reports, Yifeng Pharmacy (603939) has total liabilities worth CN¥14.41 Billion CNY (≈ $2.11 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 603939 cash flow conversion to assess how effectively this company generates cash.

Yifeng Pharmacy - Total Liabilities Trend (2011–2024)

This chart illustrates how Yifeng Pharmacy's total liabilities have evolved over time, based on quarterly financial data. Check 603939 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Yifeng Pharmacy Competitors by Total Liabilities

The table below lists competitors of Yifeng Pharmacy ranked by their total liabilities.

Company	Country	Total Liabilities
JUSUNG ENGINEERING Co. Ltd KQ:036930	Korea	₩278.20 Billion
Enphase Energy Inc NASDAQ:ENPH	USA	$2.42 Billion
CJ Corp KO:001040	Korea	₩30.66 Trillion
AIXTRON SE (UNSP.ADR/2) F:AIX2	Germany	€129.38 Million
AIXTRON SE XETRA:AIXA	Germany	€129.38 Million
Uni-President China Holdings Ltd F:58U	Germany	€10.28 Billion
IGO Ltd AU:IGO	Australia	AU$239.10 Million
PPB Group Bhd KLSE:4065	Malaysia	RM1.37 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Yifeng Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Yifeng Pharmacy.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yifeng Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yifeng Pharmacy (2011–2024)

The table below shows the annual total liabilities of Yifeng Pharmacy from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥16.58 Billion ≈ $2.43 Billion	+21.12%
2023-12-31	CN¥13.69 Billion ≈ $2.00 Billion	+14.87%
2022-12-31	CN¥11.92 Billion ≈ $1.74 Billion	+29.71%
2021-12-31	CN¥9.19 Billion ≈ $1.34 Billion	+28.18%
2020-12-31	CN¥7.17 Billion ≈ $1.05 Billion	+60.49%
2019-12-31	CN¥4.47 Billion ≈ $653.56 Million	+20.77%
2018-12-31	CN¥3.70 Billion ≈ $541.18 Million	+130.72%
2017-12-31	CN¥1.60 Billion ≈ $234.56 Million	+28.65%
2016-12-31	CN¥1.25 Billion ≈ $182.31 Million	+22.47%
2015-12-31	CN¥1.02 Billion ≈ $148.86 Million	+55.27%
2014-12-31	CN¥655.19 Million ≈ $95.87 Million	+24.99%
2013-12-31	CN¥524.21 Million ≈ $76.71 Million	+24.92%
2012-12-31	CN¥419.63 Million ≈ $61.40 Million	-13.86%
2011-12-31	CN¥487.12 Million ≈ $71.28 Million	--

About Yifeng Pharmacy

SHG:603939 China Pharmaceutical Retailers

Market Cap

$4.12 Billion

CN¥28.13 Billion CNY

Market Cap Rank

#4080 Global

#692 in China

Share Price

CN¥23.20

Change (1 day)

-0.98%

52-Week Range

CN¥21.12 - CN¥28.18

All Time High

CN¥967.78